Jennifer A. Val is a member of the Financial Services Practice, focusing her practice on capital market transactions, corporate governance, securities law compliance and other regulatory matters.
Jennifer represents issuers, underwriters, placement agents and selling security holders in a variety of public and private offerings. In recent years, she has advised US and non-US public companies on transactions that included initial public offerings, follow-on offerings, at-the-market offerings, rights offerings, PIPE transactions, Rule 144A/Regulation S offerings, and mergers and acquisitions. She counsels companies on a variety of products, including debt, medium-term notes, bank notes, convertible notes, common stock, preferred stock, warrants, limited partnership interests and hybrid securities.
Jennifer has counseled a broad spectrum of clients from large global enterprises to venture and startup companies. She brings particular expertise to clients in heavily regulated industries, such as financial services and life sciences companies, having served in an outside general counsel or corporate counsel capacity to numerous companies in those sectors.
Jennifer routinely advises public companies, boards of directors and special committees on a range of securities law and corporate governance matters, including SEC reporting and disclosure under the Securities Exchange Act of 1934, annual and special stockholder meetings, compliance with proxy rules, and compliance with NYSE and Nasdaq requirements, the Sarbanes-Oxley Act of 2002 and related regulations. She also has significant experience in dealing with financial restatements and internal control concerns.
Before pursuing a career in law, Jennifer spent years engaging in both undergraduate and PhD-level studies in a variety of areas of biology. Her graduate-level studies as part of a laboratory in Cornell University’s College of Veterinary Medicine focused primarily on molecular biology and genetics, with additional concentrations in virology and biophysics. Jennifer is a member of the US patent bar, and has been a member with periodic leadership positions of the Women in Bio’s New York Metro chapter for the better part of a decade.
Prior to joining the firm, Jennifer was senior counsel specializing in corporate transactions and securities at three prominent law firms. She also completed a secondment at the equity capital markets desk of a prominent bulge bracket investment bank.